Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
  • #4187

    I have experience using pembrolizumab for lung cancer. Is the safety profile different in those patients vs melanoma patients?


    Generally, the safety profile of pembrolizumab is similar across tumor types. However, the context may be different—patients with other tumor types may have differing comorbidities or underlying organ dysfunction. For example, lung cancer patients may have underlying lung disease that will exacerbate shortness of breath associated with pneumonitis.

Viewing 2 posts - 1 through 2 (of 2 total)
  • You must be logged in to reply to this topic.

Latest Activity